Muutke küpsiste eelistusi

Advances in genetics: Bacterial Models, Volume 115 [Kõva köide]

Series edited by (Dean of the College of Sciences and Professor of Biology, San Diego State University, USA), Series edited by (Professor Ordinaire at the University of Fribourg, Switzerland.)
  • Formaat: Hardback, 258 pages, kõrgus x laius: 229x152 mm
  • Sari: Advances in Genetics
  • Ilmumisaeg: 01-Sep-2025
  • Kirjastus: Academic Press Inc
  • ISBN-10: 0323988792
  • ISBN-13: 9780323988797
Advances in genetics: Bacterial Models, Volume 115
  • Formaat: Hardback, 258 pages, kõrgus x laius: 229x152 mm
  • Sari: Advances in Genetics
  • Ilmumisaeg: 01-Sep-2025
  • Kirjastus: Academic Press Inc
  • ISBN-10: 0323988792
  • ISBN-13: 9780323988797
Advances in Genetics, Volume 109, provides the latest information on the rapidly evolving field of genetics, presenting new medical breakthroughs that are occurring as a result of advances in our knowledge of the topic. The book continually publishes important reviews of the broadest interest to geneticists and their colleagues in affiliated disciplines, with this new release including chapters on Advances in Asthma Genetics: Filling persistent gaps, Nutritional control of postembryonic development progression and arrest in Caenorhabditis elegans, Genetic determinants of climate-resilience traits in millets, Founder variants and population genomes - towards precision medicine, and much more. Advances in Genetics, Volume 109, provides the latest information on the rapidly evolving field of genetics, presenting new medical breakthroughs that are occurring as a result of advances in our knowledge of the topic. The book continually publishes important reviews of the broadest interest to geneticists and their colleagues in affiliated disciplines, with this new release including chapters on Advances in Asthma Genetics: Filling persistent gaps, Nutritional control of postembryonic development progression and arrest in Caenorhabditis elegans, Genetic determinants of climate-resilience traits in millets, Founder variants and population genomes - towards precision medicine, and much more.
  • Critically analyzes future directions for the study of clinical genetics
  • Written and edited by recognized leaders in the field
  • Presents new medical breakthroughs that are occurring as a result of advances in our knowledge of genetics
1. Recent advances in nutrigenetics and nutrigenomics
2. Next generation
microbial drugs developed from microbiomes natural products
3. Rare
recessive alleles and founder mutations amongst heterogeneous Indian
populations
4. Genomic Precision Medicine in dilated cardiomyopathy
Kelly Hughes is Professor Ordinaire at the University of Fribourg, Switzerland. After receiving a BS degree from the University of California at Irvine and a PhD from the University of Utah working with John Roth and Baldomero Olivera, he joined Mel Simons group at Caltech as a postdoctoral fellow in 1986. He was appointed assistant professor in the Department of Microbiology at the University of Washington in Seattle in 1989 and moved up the ranks to full professor in 2001. He moved to the University of Utah in 2005 and spent 5 years in the Biology Department there before taking his current position. He was a visiting professor in Winfried Boos lab at the University of Konstanz, Germany, in 199798, in Guy Cornelis lab at the Biozentrum in Basel, Switzerland, in 2004 and in Keiichi Nambas lab at the University of Osaka in 2005 and 2007. His major research interests have focused on the biogenesis of the bacterial flagellum and coupled gene regulatory mechanisms. Stanley Maloy is Dean of the College of Sciences and a Professor of Biology at San Diego State University. He obtained a PhD from the University of California Irvine and did postdoctoral work at the University of Utah before moving to the University of Illinois. He was also Director of the UIUC Biotechnology Center government. He was the first President of the American Society for Microbiology. Research in the Maloy lab has focused on bacterial genetics, genomics, and pathogenesis, with an emphasis on Salmonella, bacterial viruses, and emerging infectious diseases. He has also been involved in translational research projects focused on new vaccine delivery systems and nanoengineering approaches for the development of narrow spectrum antibiotics.